TY  - CHAP
M1  - Book, Section
TI  - Benign Metastasizing Leiomyoma
A1  - Pacheco-Rodriguez, Gustavo
A1  - Astapova, Olga I.
A1  - Hammes, Stephen R.
A1  - Moss, Joel
A2  - Grippi, Michael A.
A2  - Antin-Ozerkis, Danielle E.
A2  - Dela Cruz, Charles S.
A2  - Kotloff, Robert M.
A2  - Kotton, Camille Nelson
A2  - Pack, Allan I.
PY  - 2023
T2  - Fishman’s Pulmonary Diseases and Disorders, 6e
AB  - Benign  metastasizing  leiomyoma  (BML)  is  a  rare  disease  of  women.  It  is  characterized  by  noninvasive,  nonaggressive,  well-circumscribed,  single  or  multiple  tumors  composed  of  differentiated  smooth  muscle  cells,  localized  to  sites  other  than  the  uterus  in  patients  with  uterine  leiomyomas1–7  and,  in  some  cases,  adnexal  tumors.8  BML  has  been  identified  in  lungs3  and  lymph  nodes9  which,  in  addition  to  uterine  leiomyomas,  are  the  most  common  sites  involved.  BMLs  have  also  been  identified  in  the  mediastinum,10,11  retroperitoneum,12  vascular  channels,13  bone,14,15  heart,16  skeletal  muscle,17  spine,18  and  pancreas.19  Pulmonary  BML  is  usually  asymptomatic  and  presents  with  either  single  or  multiple  lung  nodules  of  varying  sizes20  found  incidentally  on  chest  x-ray  or  computed  tomography  (CT)  imaging.  Occasionally,  patients  present  with  mild  or  severe  pulmonary  symptoms  due  to  BML.  Most  patients  with  BML  have  undergone  uterine  myomectomy  or  hysterectomy  due  to  leiomyomas.3,6,21,22  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1195006612
ER  -